» Articles » PMID: 37432258

Relationship Between Atherogenic Dyslipidaemia and Lipid Triad and Scales That Assess Insulin Resistance

Overview
Journal Nutrients
Date 2023 Jul 11
PMID 37432258
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Atherogenic dyslipidaemia (AD) and lipid triad (LT) are characterised by high triglyceride levels together with low HDL and normal or high LDL cholesterol and are favoured by a persistent state of insulin resistance (IR), which increases the release of free fatty acids from abdominal adipose tissue. This alteration in the lipid profile favours the accelerated development of atherosclerosis, which is the most important cause of morbidity and mortality in all countries in the developed and developing world. One of the elements that plays a major role in the genesis of AD is IR. The aim of this study was to determine the relationship between variables that assess atherogenic risk (AD and LT) and scales that assess the risk of presenting insulin resistance.

Methods: A descriptive cross-sectional study of 418,343 workers was conducted to evaluate atherogenic dyslipidaemia and lipid triad; a relationship with three insulin resistance risk scales (Triglycerides/HDL, TyG index, METS-IR) was established. The usefulness of IR risk scales for predicting AD and LT was calculated by applying ROC curves, obtaining the area under the curve (AUC) and cut-off points with their sensitivity, specificity, and Youden index. Multivariate analysis was performed by binary logistic regression.

Results: The prevalence of high-risk values for insulin resistance with all of the scales is much higher in people with AD and LT compared to those without. The ROC curves present us with an AUC with the three insulin resistance risk scales for the two dyslipidaemias studied with figures ranging between 0.856 and 0.991, which implies that the results are good/very good.

Conclusions: A relationship between atherogenic dyslipidaemia and the three insulin resistance risk scales assessed is revealed, with higher IR mean values and prevalence in people with atherogenic dyslipidaemia and lipid triad. The three scales make it possible to adequately classify the presence of AD and LT. The highest AUC is presented by the triglycerides/HDL scale, with a result close to 1. METS-IR is the most recommended formula to estimate insulin resistance.

Citing Articles

Risk of Insulin Resistance in 44,939 Spanish Healthcare Workers: Association with Sociodemographic Variables and Healthy Habits.

Tarraga Marcos P, Lopez-Gonzalez A, Martinez-Almoyna Rifa E, Paublini Oliveira H, Martorell Sanchez C, Tarraga Lopez P Diseases. 2025; 13(2).

PMID: 39997040 PMC: 11854469. DOI: 10.3390/diseases13020033.


A predictive model to assess the risk of developing hyperlipidemia in patients with type 2 diabetes.

Ye R, Huang X, Yang H, Pan W, Wang P, Men J PLoS One. 2025; 20(2):e0315781.

PMID: 39951410 PMC: 11828393. DOI: 10.1371/journal.pone.0315781.


Association between triglyceride glucose index and adverse cardiovascular prognosis in patients with atrial fibrillation without diabetes: a retrospective cohort study.

Gong A, Cao Y, Li Z, Li W, Li F, Tong Y Lipids Health Dis. 2025; 24(1):23.

PMID: 39863861 PMC: 11762522. DOI: 10.1186/s12944-025-02447-3.


Identification of Interactive Genetic Loci Linked to Insulin Resistance in Metabolic Syndrome-An Update.

Elfaki I, Mir R, Elnageeb M, Hamadi A, Alharbi Z, Bedaiwi R Medicina (Kaunas). 2025; 61(1).

PMID: 39859066 PMC: 11767019. DOI: 10.3390/medicina61010083.


Hemoglobin A1c and abdominal obesity as predictors of diabetes and ASCVD in individuals with prediabetes in UK Biobank: a prospective observational study.

Pencina K, Thanassoulis G, Pencina M, Toth P, Sniderman A Cardiovasc Diabetol. 2024; 23(1):448.

PMID: 39702291 PMC: 11660550. DOI: 10.1186/s12933-024-02525-3.


References
1.
Chen Y, Chang Z, Liu Y, Zhao Y, Fu J, Zhang Y . Triglyceride to high-density lipoprotein cholesterol ratio and cardiovascular events in the general population: A systematic review and meta-analysis of cohort studies. Nutr Metab Cardiovasc Dis. 2021; 32(2):318-329. DOI: 10.1016/j.numecd.2021.11.005. View

2.
Grundy S . Atherogenic dyslipidemia associated with metabolic syndrome and insulin resistance. Clin Cornerstone. 2006; 8 Suppl 1:S21-7. DOI: 10.1016/s1098-3597(06)80005-0. View

3.
Ramirez-Manent J, Jover A, Martinez C, Tomas-Gil P, Marti-Lliteras P, Lopez-Gonzalez A . Waist Circumference Is an Essential Factor in Predicting Insulin Resistance and Early Detection of Metabolic Syndrome in Adults. Nutrients. 2023; 15(2). PMC: 9861022. DOI: 10.3390/nu15020257. View

4.
Li M, Chi X, Wang Y, Setrerrahmane S, Xie W, Xu H . Trends in insulin resistance: insights into mechanisms and therapeutic strategy. Signal Transduct Target Ther. 2022; 7(1):216. PMC: 9259665. DOI: 10.1038/s41392-022-01073-0. View

5.
Kheirollahi A, Teimouri M, Karimi M, Vatannejad A, Moradi N, Borumandnia N . Evaluation of lipid ratios and triglyceride-glucose index as risk markers of insulin resistance in Iranian polycystic ovary syndrome women. Lipids Health Dis. 2020; 19(1):235. PMC: 7648985. DOI: 10.1186/s12944-020-01410-8. View